MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Characteristics of lower gastrointestinal tract dysfunction in patients with Parkinson disease

    T. Uchiyama, T. Yamamoto, K. Suzuki, T. Kadowaki, H. Nakajima, R. Sakakibara, S. Kuwabara, K. Hirata, M. Murai (Chiba, Japan)

    Objective: To evaluate the characteristics of lower gastrointestinal tract dysfunction in patients with Parkinson disease (PD). Background: Lower gastrointestinal tract dysfunction is common in patients…
  • 2019 International Congress

    Motor and non-motor symptoms related to sleep disturbances in Parkinson’s disease

    D. van Wamelen, V. Leta, A. Podlewska, Y. Wan, A. Sauerbier, A. Rizos, P. Martinez-Martin, K. Chaudhuri (Madrid, Spain)

    Objective: To assess which (non-)motor symptoms are associated with the longitudinal development of sleep disturbances, one of the major non-motor symptoms (NMS) in Parkinson’s disease…
  • 2019 International Congress

    Impulse Control Disorders in a Brazilian population with Parkinson´s disease -an observational study

    B. Veiga, V. Borges, H. Ferraz, C. Aquino, C. Giacominelli, SM. Silva, S. Lestingi (São Paulo, Brazil)

    Objective: To Analyse Impulse Control Disorders (ICDs) and Related Behaviors (RB) in 36 Brazilian patients with Parkinson´s disease (PD) and compare the cognition of the…
  • 2019 International Congress

    Glycopyrrolate as inhalation for treating sialorrhea in Parkinson’s Disease

    L. Velzen, J. Masselink, L. Dorresteijn, K. Movig (Enschede, Netherlands)

    Objective: To evaluate the safety, tolerability and effect of glycopyrrolate inhalations in PD patients with sialorrhea. Background: Sialorrhea is reported in up to 60 percent…
  • 2019 International Congress

    Exploratory analysis of the relationship between pain and mood disturbances in Parkinson’s disease

    C. Vila, A. Sparks, P. Imbriani, N. Caputi, L. Covington, T. Schirinzi, S. Natoli, A. Pisani, P. Ghosh (Washington, DC, USA)

    Objective: This study aims to investigate the relationship between pain and mood disturbances in patients with Parkinson disease (PD). Background: Pain and mood disturbances are…
  • 2019 International Congress

    Effect of Deep brain stimulation and Continuous infusion of levodopa-carbidopa intestinal therapy on non-motor symptoms in patients with advance Parkinson’s disease

    V. Vuletic (Rijeka, Croatia)

    Objective: Our aim was to see effects of deep brain stimulation (DBS) and continuous infusion of levodopa-carbidopa intestinal gel (LCIG) on nonmotor symptoms in advanced…
  • 2019 International Congress

    Frequency, course and predictors of fatigue in Parkinson’s disease patients and population-based controls

    E. Warrlich, EJ. Vollstedt, R. Modreanu, B. Hauptmann, V. Tadic, S. Tunc, C. Kritzinger, J. Prasuhn, A. Balck, M. Borsche, H. Hanssen, N. Brüggemann, C. Klein, M. Kasten (Luebeck, Germany)

    Objective: To assess fatigue frequency, course, and predictors in a large and diverse cohort of Parkinson’s disease (PD) patients and controls. Background: Fatigue is a…
  • 2019 International Congress

    Characterizing olfactory impairment in patients with Parkinson’s disease and related disorders

    Y. Watanabe, K. Suzuki (Mibu, Shimotsuga, Tochigi, Japan)

    Objective: To characterize olfactory impairment in Parkinson’s disease (PD), multiple system atrophy (MSA) and progressive supranuclear palsy (PSP). Background: In the previous study, we found…
  • 2019 International Congress

    Cognitive and psychiatric course in the initial lustrum of Parkinson disease: the glass is half full

    D. Weintraub, C. Caspell-Garcia, H. Cho, T. Simuni, A. Siderowf, C. Coffey, D. Aarsland, R. Alcalay, L. Chahine, J. Eberling, A. Espay, J. Hamilton, J. Leverenz, I. Litvan, I. Richard, L. Rosenthal, M. York (Philadelphia, PA, USA)

    Objective: To describe the cognitive-psychiatric course in the first 5 years of diagnosed Parkinson disease (PD). Background: Although common, little is known about the differential…
  • 2019 International Congress

    Non-motor symptoms burden grading in Parkinson disease with the Movement Disorders Society – Non-Motor Rating Scale (MDS-NMS)

    D. Weintraub, C. Rodriguez-Blazquez, A. Schrag, A. Rizos, KR. Chaudhuri, P. Martinez-Martin (Madrid, Spain)

    Objective: To identify cut-off points on the Movement Disorders Society – Non Motor Rating Scale (MDS-NMS) for non-motor symptoms (NMS) burden grading. Background: NMS burden…
  • « Previous Page
  • 1
  • …
  • 1343
  • 1344
  • 1345
  • 1346
  • 1347
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley